Business And Finance Magazines

Regenerative medicine is known as the type of medicine that makes use the stem cell-based technology. It focuses on encouraging new cells to grow and bring solution to ineffective treatments for rare and common diseases. William M. Caldwell IV is a person who is closely related to the field of stem cell technology. The man is the Chief Executive Officer of Advance Cell Technology, Inc which is a leading company in the field of biotechnology. This company develops cellular therapies to help millions of people all over the world. The aim of this company is to come up with therapies that are patient-specific. Currently, the company is focused in their three product areas. One of those product areas is the Retinal Pigment Epithelium (RPE) program.

This program is resulting in therapies to treat disease indications and disorders like the AMD which stand for age-related macular degeneration. The first therapeutic treatment using the RPE therapy was a treatment that was intended to treat Stargardt’s Disease. The second product area is the hemangioblast (HG) cell program. This is intended for cardiac diseases like heart failure. After succeed the Phase I, the company is now looking forward to continue the Phase II. The third product are that William M. Caldwell IV and Advance Cell Technology, Inc. are focused on is their myoblast program. It is not a surprise that Advance Cell Technology, Inc is this successful remembering that the CEO, William M. Caldwell IV is the man with abundant experience in business. In his current position, he dedicates his work to the wellbeing of the humanity.